Tutorials › Propensity Score Matching and Instrumental Variables › The Effective F Statistic

Weak-Instrument Diagnostics · Tutorial 523 of 699

The Effective F Statistic

Understand the effective F statistic’s heteroskedasticity-robust construction, its assumptions, and why its calibrated thresholds—not a universal rule of thumb—guide interpretation.

Advanced 12 min read

What You'll Learn

  • Define the effective F statistic for a first stage with one endogenous regressor.
  • Derive its connection to first-stage signal and sandwich-estimated uncertainty.
  • Distinguish effective F from conventional and heteroskedasticity-robust Wald F statistics.
  • Interpret critical values in relation to a stated strength criterion.
  • Identify assumptions, diagnostic warnings, and limits on its use.

Why a Different First-Stage Strength Statistic?

With heteroskedastic errors, the conventional first-stage F statistic uses a variance calculation that may not reflect how uncertainty changes across observations. A heteroskedasticity-robust Wald test addresses that variance problem, but it is not automatically interchangeable with a statistic calibrated to assess weak-instrument bias and inference. The effective F statistic is designed to measure first-stage strength in a way that accounts for heteroskedasticity and can be compared with critical values calibrated to a specified weak-instrument criterion.

This is a strength diagnostic, not a test of whether the instruments satisfy the exclusion restriction or are otherwise valid. Strong prediction of the endogenous regressor does not establish instrument validity. The earlier material on the first-stage F statistic, robust first-stage tests, and the Kleibergen-Paap rk Wald F statistic provides useful comparisons; the focus here is what the effective F adds under heteroskedasticity.

Definition and Assumptions

Consider a first stage with one endogenous regressor \(x\), \(K\) excluded instruments collected in the \(n \times K\) matrix \(Z\), and included exogenous controls. Partial out the controls from \(x\) and \(Z\), and write the resulting first-stage model as \(x=Z\pi+v\). Here \(\pi\) is the vector of first-stage coefficients and \(v\) is the first-stage error. For compactness, the residualized variables are written without separate notation.

Let \(Q=Z'Z\), let \(\hat{\pi}\) be the least-squares estimate of \(\pi\), and let \(\hat{v}_i\) be the first-stage residual for observation \(i\), with \(z_i\) denoting its residualized instrument vector. The heteroskedasticity-robust sandwich estimate of the covariance matrix of \(\hat{\pi}\) is

$$ \widehat{V}_{\pi} =Q^{-1}\left(\sum_{i=1}^n z_i z_i'\hat{v}_i^2\right)Q^{-1}. $$

The effective F statistic is the estimated first-stage signal, measured in the \(Q\) metric, divided by the robust uncertainty averaged across the \(K\) instrument directions:

$$ F_{\mathrm{eff}} = \frac{\hat{\pi}'Q\hat{\pi}} {\operatorname{tr}(Q\widehat{V}_{\pi})} = \frac{\hat{\pi}'Q\hat{\pi}} {\operatorname{tr}\!\left[ Q^{-1}\sum_{i=1}^n z_i z_i'\hat{v}_i^2 \right]}. $$
Definition: The effective F statistic is a heteroskedasticity-robust measure of first-stage strength for a model with one endogenous regressor. Its numerator measures fitted instrument signal; its denominator summarizes robust estimation uncertainty across the excluded-instrument directions. Strength is assessed by comparing it with critical values calibrated for a stated criterion, not by applying one universal cutoff.

The usual setting assumes independent observations, a correctly specified linear first-stage projection, a full-rank excluded-instrument matrix after partialling out controls, and finite moments sufficient for the sandwich covariance estimate to be meaningful. Heteroskedasticity is allowed: the variance of \(v_i\) need not be constant across observations. Instrument exogeneity and relevance remain substantive requirements of IV analysis; the statistic does not verify exogeneity. Its heteroskedasticity-robust calibration should not be assumed to cover clustered dependence.

Why the Statistic Has This Form

The connection to the familiar homoskedastic first-stage measure follows directly from the denominator. Under homoskedasticity, suppose \(\operatorname{Var}(v_i\mid Z)=\sigma^2\). Then the population counterpart of the sandwich “meat” is \(\sigma^2Q\), so the covariance matrix is approximately \(\sigma^2 Q^{-1}\). Consequently,

$$ \operatorname{tr}(Q\widehat{V}_{\pi}) \approx \operatorname{tr}(Q\sigma^2Q^{-1}) = K\sigma^2. $$

Thus, in the homoskedastic case, the effective F has the form \(\hat{\pi}'Q\hat{\pi}/(K\sigma^2)\): instrument signal divided by the average noise per instrument direction. With heteroskedasticity, the sandwich covariance replaces the single common variance, and its trace supplies the corresponding aggregate uncertainty measure.

This also explains why the effective F need not equal the robust Wald F. The robust Wald statistic uses the inverse of the estimated covariance matrix to weight the first-stage coefficients, whereas the effective F compares signal with the trace-based average uncertainty. Under general heteroskedasticity, those are different summaries of the same estimates.

Worked Example: Calculating Effective F From First-Stage Summaries

Suppose a hypothetical analysis has two excluded instruments and, after partialling out controls, reports \(Q=100I_2\), \(\hat{\pi}=(0.30,0.20)'\), and \(\sum_i z_i z_i'\hat{v}_i^2=\operatorname{diag}(100,400)\). These are illustrative summary quantities, not findings from a real study.

First calculate the instrument signal:

$$ \hat{\pi}'Q\hat{\pi} = 100(0.30^2+0.20^2) = 100(0.13) = 13. $$

The robust covariance estimate is

$$ \widehat{V}_{\pi} = (100I_2)^{-1} \begin{pmatrix}100&0\\0&400\end{pmatrix} (100I_2)^{-1} = \begin{pmatrix}0.01&0\\0&0.04\end{pmatrix}. $$

Therefore the denominator is

$$ \operatorname{tr}(Q\widehat{V}_{\pi}) = 100(0.01)+100(0.04) = 5, \qquad F_{\mathrm{eff}}=\frac{13}{5}=2.60. $$

The effective F is 2.60. That number alone does not establish a universal pass-or-fail result: interpretation requires a critical value calibrated for the instrument count, significance level, and strength criterion of interest.

Comparison With Other First-Stage Statistics

The statistics below answer related but not identical questions. In particular, a robust covariance estimate does not by itself make a statistic’s weak-instrument critical values appropriate for the effective-F criterion.

StatisticWhat it summarizesKey caution
Conventional first-stage FExcluded-instrument explanatory power using the homoskedastic variance calculationIts usual inference can be unreliable under heteroskedasticity.
Heteroskedasticity-robust Wald FA robust Wald test of the joint null that the excluded-instrument coefficients are zero, often reported as the Wald statistic divided by \(K\)It is a robust first-stage test, but should not be treated as the effective F or compared automatically with effective-F critical values.
Effective FFirst-stage signal relative to trace-averaged robust uncertainty, with strength thresholds calibrated to a chosen criterionIt assesses strength under its calibration assumptions; it does not test instrument validity.
Kleibergen-Paap rk Wald FA robust rank-based diagnostic commonly used in IV settingsIts value and critical-value interpretation are not interchangeable with those of effective F.

Worked Example: Why Robust Wald F and Effective F Can Differ

Use the hypothetical summaries in the preceding calculation. The robust Wald statistic for the joint null \(\pi=0\) is \(\hat{\pi}'\widehat{V}_{\pi}^{-1}\hat{\pi}\). Since \(\widehat{V}_{\pi}^{-1}=\operatorname{diag}(100,25)\),

$$ \hat{\pi}'\widehat{V}_{\pi}^{-1}\hat{\pi} = 0.30^2(100)+0.20^2(25) = 9+1 = 10. $$

With \(K=2\), the robust Wald F reported as the Wald statistic divided by \(K\) is \(10/2=5.00\). The effective F calculated above is 2.60. Both use the same first-stage estimates and robust covariance information, but the Wald statistic weights directions using the inverse covariance, while effective F uses the trace-based average uncertainty. A difference between them is therefore possible and is not, by itself, evidence of a calculation error.

If the same \(\hat{\pi}\) and \(Q\) were paired with a hypothetical robust covariance estimate \(\widehat{V}_{\pi}=0.01I_2\), the effective-F denominator would be \(100(0.01)+100(0.01)=2\), giving \(F_{\mathrm{eff}}=13/2=6.50\). The robust Wald F would also be \(6.50\) in this special equal-variance case. In general, however, the two statistics need not agree.

Using Calibrated Critical Values

Effective-F critical values are tied to a specified benchmark for how weak instruments may be before a chosen performance criterion is exceeded. Depending on the calibration, that criterion can concern the maximum relative bias of an IV estimator or distortion in nominal test size. The threshold therefore depends on the number of excluded instruments and the selected criterion and significance level. It is not a universal value such as 10.

A comparison with the matching critical value gives a conditional diagnostic: a statistic below the threshold signals that the specified strength criterion is not met under the calibration; a statistic above it indicates that the criterion is met under those assumptions. Neither outcome establishes instrument validity, and crossing a threshold does not guarantee accurate inference in every design.

Worked Example: Interpreting a Calibrated Threshold

Suppose a hypothetical analysis has one endogenous regressor and two excluded instruments. For a prespecified calibration, software reports an effective-F critical value of 16.4, and the analysis gives \(F_{\mathrm{eff}}=18.7\). The value 16.4 here is stipulated as an output of that hypothetical calibration; it is not a general critical value.

The comparison is \(18.7>16.4\). The statistic exceeds the threshold, so it meets the strength criterion used for this calibration. The appropriate conclusion is limited to that criterion and its assumptions. It is not correct to conclude that the instruments are valid, that weak-IV concerns are impossible, or that every conventional IV confidence interval will have nominal coverage.

If instead the effective F were 12.0, then \(12.0<16.4\), so the stated criterion would not be met. This flags a strength concern; it does not prove that the instruments are irrelevant or that every IV estimate is unusable.

Diagnostics, Failure Modes, and Limits

Before interpreting a reported effective F, check what model and covariance estimator produced it. The statistic should be based on the first stage for the endogenous regressor, with included controls handled consistently in the residualized design. Verify the number of excluded instruments and that the reported threshold uses the same instrument count and the intended bias or size criterion. If the data have clustered dependence, a heteroskedasticity-only calibration is not automatically appropriate; the covariance and critical-value procedure must match the dependence structure.

Large differences between conventional, robust Wald, and effective F statistics can be informative. They may reflect heteroskedasticity concentrated in particular instrument directions. Inspect the first-stage specification and the variance estimator rather than selecting whichever statistic appears most reassuring. Also check that the instrument design has adequate rank after controls are included; rank deficiency makes the stated calculation unsuitable.

The effective F is specifically useful for a single endogenous regressor under its stated calibration. Its scalar summary does not reveal which instrument direction carries the signal or uncertainty. It also does not diagnose exclusion-restriction violations, omitted-variable problems, or sensitivity to influential observations. No strength statistic replaces substantive justification of the instruments or a full assessment of IV inference.

  • Mistake: “The robust Wald F is robust, so it is the effective F.” Robustness of a covariance estimate does not make the statistics identical. Calculate or obtain the effective F and use its own matching critical values.
  • Mistake: “Effective F above 10 proves the instruments are strong.” There is no universal cutoff. Compare against the threshold for the chosen criterion and design.
  • Mistake: “A high effective F proves instrument validity.” Strength concerns first-stage prediction; validity requires separate design-based justification.
  • Mistake: “Heteroskedasticity robust means cluster robust.” Allowing observation-specific variances does not automatically account for within-cluster dependence.
Key takeaway: Effective F compares first-stage signal with heteroskedasticity-robust uncertainty averaged across instrument directions. Its value is meaningful for strength assessment only alongside a critical value calibrated to the relevant instrument count, criterion, and assumptions.

Check Your Understanding

Answer each question, then compare with the brief solutions.

  1. In the effective-F formula, what does the numerator measure, and what does the denominator summarize?
  2. Suppose a hypothetical model has \(K=2\), \(\hat{\pi}'Q\hat{\pi}=18\), and \(\operatorname{tr}(Q\widehat{V}_{\pi})=6\). Calculate effective F.
  3. Why can the heteroskedasticity-robust Wald F differ from effective F?
  4. A statistic exceeds its matching effective-F critical value. Name one conclusion that is justified and one that is not.
  5. Why is an ordinary heteroskedasticity-robust effective-F calculation not automatically suitable for clustered observations?

Solutions. (1) The numerator measures fitted instrument signal; the denominator summarizes sandwich-estimated uncertainty across the \(K\) directions. (2) \(F_{\mathrm{eff}}=18/6=3.00\). Its strength interpretation still requires the matching threshold. (3) The Wald statistic uses inverse-covariance weighting, while effective F divides signal by trace-averaged uncertainty. (4) It is justified to say the specified calibration criterion is met under its assumptions; it is not justified to claim instrument validity is proven. (5) Heteroskedasticity robustness allows nonconstant variances across independent observations but does not, by itself, account for dependence within clusters.

Clinical Biostats